Anti-V5-tag pAb-Agarose (Polyclonal Antibody)
V5-tag Polyclonal Antibody.
Specifications:
Description
Polyclonal Antibody conjugated to agarose of gel: 200 µl targeting V5-tag for IP.
| Target: | V5 |
|---|---|
| Product Type: | Antibody |
| Size: | Gel: 200 µL |
| Application: | IP |
| Research Area / Disease: | Epitope Tag |
| Conjugate: | Agarose |
| Antibody Type: | Polyclonal |
| Formulation: | 400 μg of anti-V5-tag polyclonal antibody covalently coupled to 200 μl of agarose gel and provided as a 50% gel slurry suspended in PBS containing preservative (0.09% sodium azide) for a total volume of 400 μl.*Azide |
| Isotype: | Affinity Purified Ig |
| Immunogen: | Binding synthetic peptide carrier protein (CP-GKPIPNPLLGLDST) |
| Host Species: | Rabbit |
| Source: | This antibody was purified from rabbit serumusing affinity column. The rabbit was immunized withcarrier protein (CP) conjugated synthetic peptide,CP-GKPIPNPLLGLDST. |
| Reactivity: | This antibody recognizes V5-tagpeptide sequence (GKPIPNPLLGLDST) onImmunoprecipitation. |
| Storage Temperature: | 4°C |
| Regulatory Statement: | For Research Use Only. Not for use in diagnostic procedures. |
Citations
- Uenaka T et al. In silico drug screening by using genome-wide association study data repurposed dabrafenib, an anti-melanoma drug, for Parkinson’s disease. Hum Mol Genet. 27, 3974-3985 (2018)
- Taira J et al. Dephosphorylation of clustered phosphoserine residues in human Grb14 by protein phosphatase 1 and its effect on insulin receptor complex formation. J Pept Sci. 25, e3207 (2019)
Related Content:
Blog
Epitope tag